NCT03209895

Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain

A Double-Blinded, Placebo Controlled, Human Clinical Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 135 (actual)
• Sponsor: U.S. Nutraceuticals, LLC · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This study is designed to evaluate the effectiveness of a proprietary nutritional supplement that contains Krill Oil (KO), astaxanthin (AX) and hyaluronic acid (HA) to reduce pain and discomfort in participants, compared to an inert placebo (palm oil) control and to a positive control (glucosamine-chondroitin). The purpose of the study is to determine if the combination of KO, AX, and HA will benefit participants with joint pain.

Conditions

• Joint Pain

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Joint Health Product	Krill oil, Astaxanthin, Hyaluronic Acid Formulation, 353 mg per day; Softgel capsule
DIETARY_SUPPLEMENT	Placebo	Palm oil Softgel capsule
DIETARY_SUPPLEMENT	Glucosamine / Chondroitin	Glucosamine 1500 mg, Chondroitin 1200 mg per day

Timeline

• Start date: 2010-10-08
• Primary completion: 2011-06-13
• Completion: 2011-06-13
• First posted: 2017-07-06
• Last updated: 2017-07-06

Locations

1 site across 1 country: United States